Home  |  Archive  |  AJA @ Nature  |  Online Submission  |  News & Events  |  Subscribe  |  APFA  |  Society  |  Links  |  Contact Us  |  中文版

 

- Advance Online Publication
- Current Issue
- Free Sample Issue
- Browse by Volume
- Browse by Category
- Acknowledgments
- Special Issues
- AJA @ NPG

- Online Submission
- Online Review
- Instruction for Authors
- Instruction for Reviewers
- English Corner

- About AJA
- Editorial Board
- Contact Us
- News

- Nature.com
- Nature Publishing Group

- Advertisement
- Subscription
- Email alert
- Proceedings
- Reprints

- Copyright Licence
- Subscription
- Free Sample

- Journals
- Societies & Institutes
- Hospitals
- Databases & Libraries
- Companies
- Websites
- Meetings
- Other links

Editorial Board

  Somboon Leungwattanakij

Associate Professor
The Family Health Planning, Division of Urology, Department of Surgery, Ramathibodi Hospital, Mahidol University, 270 Rama VI Road, Rajathevi, Bangkok, Thailand 10400.
Tel: +66-2-201 1315        Fax: +66-2-201 1316
Email: ptuaja@hotmail.com

Education
1988: MD., Ramathibodi Hospital, Mahidol University
1994: Diploma, Thai Board of Urology
1999-2001: Fellow, Andrology Section, Department of Urology, Tulane Hospital, New Orleans, LA, USA

Clinical, Molecular and Animal Studies

  1. Asian Sildenafil (Viagra) Safety and Efficacy Study (ASSES) in Thailand, Phase III multi-center study in 130 patients, 1997-8.

  2. Medicated urethral system for erection (MUSE), Phase IV multi-center study, 1998.

  3. Study of efficacy and safety of tamsulozin (Harnal) in Thai people, Phase IV multi-center study, 1999.

  4. Evaluation of cadaveric pericardium in the surgical treatment of Peyronie?s disease using a rat model. Department of Urology, Tulane University Medical Center, New Orleans, LA, 70112, USA, 1999-2000.

  5. A rat model of Peyronie?s disease in erectile activity and an increase in inducible nitric oxide synthase protein expression, Department of Urology, Tulane University Medical Center, New Orleans, LA, 70112, USA, 1999-2000.

  6. The safety and efficacy of Interferon alpha 2b in patients with Peyronie?s disease. Tulane University Medical Center, New Orleans, LA, 70112, USA, 1999-2000.

  7. Comparing the efficacy of cadaveric pericardium, vein, Gore-Tex and dermal graft in the surgical treatment of Peyronie?s disease using a rat model. Tulane University Medical Center, New Orleans, LA, 70112, USA, 1999-2000.

  8. Effect of cavernous nerve neurectomy to TGF beta1, collagen I and III, and corporal fibrosis in a rat model. Tulane University Medical Center, New Orleans, LA, 70112, USA, 1999-2000.

  9. Prevention of erectile dysfunction after nerve-sparing radical prostatectomy with early topical alprostadil and oral sildenafil. Tulane University Medical Center, New Orleans, LA, 70112, USA, 2000-2001.

  10. Effect of cavernous nerve neurectomy to endothelin-1 receptor using a rat model. Tulane University Medical Center, New Orleans, LA, 70112, USA, 2000-2001.

  11. Effect of cavernous nerve neurectomy to dopaminergic-1 and-2 receptors using a rat model. Tulane University Medical Center, New Orleans, LA, 70112, USA, 2000-2001.

  12. Cavernous tissue regeneration using porcine small intestinal submucosa for penile reconstruction in a rat model. Tulane University Medical Center, New Orleans, LA, 70112, USA, 2000-2001.

  13. Assessment of in-vivo performance of antimicrobial-soaked Bioflex?coated with Resist? Tulane University Medical Center, New Orleans, LA, 70112, USA, 2001.

  14. The efficacy and safety of sildenafil (Viagra) in dylipidemia, hypertensive and diabetes patients, multicenter study, 2001-2.

  15. Randomized, double blind, placebo controlled, parallel group, multi-centre, multinational study to evaluate the efficacy and tolerability of vardenafil (Bay 38-9456) in treatment of male erectile dysfunction 2002-3.

  16. Alfuzosin XL-lower urinary tract symptoms efficacy and sexuality study (multi-centre study) 2003-4. Alex

  17. Effect of cavernous neurotomy on dopamine receptor in rat penis.

  18. Efficacy and safety of treatment with dutasteride (0.5 mg) and tamsulosin (0.4 mg), administered once daily for 4 years.

Publications (.html)

 

Copyright 1999-2013    Shanghai Materia Medica, Shanghai Jiao Tong University.    All rights reserved